The Company successfully launched the production trials of BAM-1, its newest and most robust recombinant spider silk production silkworm hybrid, on time and in line with its production roadmap. The Company's CEO remains in
Following health screenings and daily monitoring of the colony, the Company can now report that this is currently the strongest and healthiest batch of silkworms it has ever produced in
"Our team invested heavily in improving the robustness of our production recombinant spider silk strains based on hard lessons learned and the testing data collected in 2023. With the support and added insight Dr.
To view the most recent news from
About
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
(720) 288-8495
ir@KraigLabs.com
Source:
2024 GlobeNewswire, Inc., source